ETAPA I: Peptide-based Tumor Associated Antigen Vaccine in GBM
Clinical trial NCT05283109 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05283109
- Sponsor
- Mustafa Khasraw, MBChB, MD, FRCP, FRACP
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-30
- Primary completion
- 2025-04-11
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.